Tyra Biosciences, Inc. (TYRA) Latest Stock News & Headlines
Get the latest Tyra Biosciences, Inc. (TYRA) stock news and headlines to help you in your trading and investing decisions.
TYRA News Today | Why did Tyra Biosciences stock go up today?
4 days ago · What's going on at Tyra Biosciences (NASDAQ:TYRA)? Read today's TYRA news from trusted media outlets at MarketBeat.
Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History ...
Find the latest Tyra Biosciences, Inc. (TYRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Tyra Biosciences initiated with a Buy at UBS - Markets Insider
3 days ago · UBS analyst Eliana Merle initiated coverage of Tyra Biosciences (TYRA) with a Buy rating and $28 price target Tyra Biosciences is a clinical-stage biotech company with a drug, TYRA-300, in ...
Tyra Biosciences (TYRA) Stock Price, News & Analysis - MarketBeat
Jan 3, 2025 · Should You Buy or Sell Tyra Biosciences Stock? Get The Latest TYRA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
Tyra Biosciences’ TYRA-300 shows anti-tumor activity in proof-of ...
Oct 24, 2024 · Tyra Biosciences (TYRA) announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial – mUC – cancer from its ongoing SURF301 Phase 1/2 study. These data will be...
Tyra Biosciences Announces Late-Breaking Oral Presentation on ...
Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth...
UBS Initiates Coverage of Tyra Biosciences (TYRA) with Buy ...
As of December 23, 2024, the average one-year price target for Tyra Biosciences is $31.62/share. The forecasts range from a low of $29.29 to a high of $34.65. The average price target represents ...
Tyra Biosciences to Host Conference Call on Interim Clinical Data …
Oct 23, 2024 · TYRA is hosting a conference call and webcast on October 25, 2024, at 8am ET to review the interim clinical data demonstrated with TYRA-300 in mUC. Participants may access a live webcast of the call and the associated slide presentation on the " For Investors " page of the TYRA website at https://ir.tyra.bio .
Tyra Biosciences, Inc. (TYRA) Latest Stock News - Seeking Alpha
Get the latest news and real-time alerts from Tyra Biosciences, Inc. (TYRA) stock at Seeking Alpha.
- Some results have been removed